BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11781820)

  • 21. Requirement of caspase-mediated cleavage of c-Abl during stress-induced apoptosis.
    Machuy N; Rajalingam K; Rudel T
    Cell Death Differ; 2004 Mar; 11(3):290-300. PubMed ID: 14657961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.
    Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Santucci MA
    Traffic; 2009 Jun; 10(6):637-47. PubMed ID: 19220809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation and consequent stimulation of the tyrosine kinase c-Abl by PKA in mouse spermatozoa; its implications during capacitation.
    Baker MA; Hetherington L; Curry B; Aitken RJ
    Dev Biol; 2009 Sep; 333(1):57-66. PubMed ID: 19560455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Physical and functional interaction between hMSH5 and c-Abl.
    Yi W; Lee TH; Tompkins JD; Zhu F; Wu X; Her C
    Cancer Res; 2006 Jan; 66(1):151-8. PubMed ID: 16397227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. c-Abl is required for staurosporine-induced caspase activity.
    Oxhorn BC; Sanguinetti AR; Mastick CC; Buxton IL
    Proc West Pharmacol Soc; 2005; 48():110-7. PubMed ID: 16416674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-Abl proto-oncoprotein is expressed and tyrosine phosphorylated in human sperm cell.
    Naz RK
    Mol Reprod Dev; 1998 Oct; 51(2):210-7. PubMed ID: 9740329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. c-Abl: activation and nuclear targets.
    Shaul Y
    Cell Death Differ; 2000 Jan; 7(1):10-6. PubMed ID: 10713716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery and characterization of a cell-permeable, small-molecule c-Abl kinase activator that binds to the myristoyl binding site.
    Yang J; Campobasso N; Biju MP; Fisher K; Pan XQ; Cottom J; Galbraith S; Ho T; Zhang H; Hong X; Ward P; Hofmann G; Siegfried B; Zappacosta F; Washio Y; Cao P; Qu J; Bertrand S; Wang DY; Head MS; Li H; Moores S; Lai Z; Johanson K; Burton G; Erickson-Miller C; Simpson G; Tummino P; Copeland RA; Oliff A
    Chem Biol; 2011 Feb; 18(2):177-86. PubMed ID: 21338916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).
    Nagar B; Bornmann WG; Pellicena P; Schindler T; Veach DR; Miller WT; Clarkson B; Kuriyan J
    Cancer Res; 2002 Aug; 62(15):4236-43. PubMed ID: 12154025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural basis for the autoinhibition of c-Abl tyrosine kinase.
    Nagar B; Hantschel O; Young MA; Scheffzek K; Veach D; Bornmann W; Clarkson B; Superti-Furga G; Kuriyan J
    Cell; 2003 Mar; 112(6):859-71. PubMed ID: 12654251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.
    Schindler T; Bornmann W; Pellicena P; Miller WT; Clarkson B; Kuriyan J
    Science; 2000 Sep; 289(5486):1938-42. PubMed ID: 10988075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A myristoyl/phosphotyrosine switch regulates c-Abl.
    Hantschel O; Nagar B; Guettler S; Kretzschmar J; Dorey K; Kuriyan J; Superti-Furga G
    Cell; 2003 Mar; 112(6):845-57. PubMed ID: 12654250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two distinct phosphorylation pathways have additive effects on Abl family kinase activation.
    Tanis KQ; Veach D; Duewel HS; Bornmann WG; Koleske AJ
    Mol Cell Biol; 2003 Jun; 23(11):3884-96. PubMed ID: 12748290
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reciprocal regulation of Abl and receptor tyrosine kinases.
    Srinivasan D; Kaetzel DM; Plattner R
    Cell Signal; 2009 Jul; 21(7):1143-50. PubMed ID: 19275932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The SH2 domain of Abl kinases regulates kinase autophosphorylation by controlling activation loop accessibility.
    Lamontanara AJ; Georgeon S; Tria G; Svergun DI; Hantschel O
    Nat Commun; 2014 Nov; 5():5470. PubMed ID: 25399951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HRD Motif as the Central Hub of the Signaling Network for Activation Loop Autophosphorylation in Abl Kinase.
    La Sala G; Riccardi L; Gaspari R; Cavalli A; Hantschel O; De Vivo M
    J Chem Theory Comput; 2016 Nov; 12(11):5563-5574. PubMed ID: 27682200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. c-Abl is an effector of Src for growth factor-induced c-myc expression and DNA synthesis.
    Furstoss O; Dorey K; Simon V; BarilĂ  D; Superti-Furga G; Roche S
    EMBO J; 2002 Feb; 21(4):514-24. PubMed ID: 11847100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.
    Pendergast AM; Muller AJ; Havlik MH; Clark R; McCormick F; Witte ON
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5927-31. PubMed ID: 1712111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms.
    Welch PJ; Wang JY
    Mol Cell Biol; 1995 Oct; 15(10):5542-51. PubMed ID: 7565706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.